Table 1.
Baseline characteristics of patients with NAFLD participated in our study before interventiona
| Variables | Placebo group | Curcumin group | P value |
|---|---|---|---|
| Age (year) | 10.9 ± 45.13 | 11.5 ± 46.19 | 0.473 |
| Sex (male, n,(%)) | 14 (51.9%) | 13 (48.1%) | 0.407 |
| Physical Activity (MET.h.d) | 4.63 ± 32.03 | 3.65 ± 32.69 | 0.592 |
| Smoking | 0.167 | ||
| Yes (Smoker or Ex-smoker) | 4 (17%) | 1 (4%) | |
| No (Never smoked) | 19 (83%) | 26 (96%) | |
| Weight (kilogram) | 89.22 ± 13.05 | 85.02 ± 11.16 | 0.225 |
| BMI (kg/m2) | 32.38 ± 5.02 | 32.30 ± 4.55 | 0.956 |
| Waist circumference (cm) | 103.28 ± 8.83 | 102.19 ± 8.78 | 0.948 |
| Total energy (kcal) | 2323.01 ± 540.59 | 2355.41 ± 703.69 | 0.858 |
| hs-CRP (ng/dL) | 6705.05 ± 4797.9 | 5647.15 ± 3858.4 | 0.412 |
| TNF-α (pg/mL) | 18.63 ± 2.2 | 19.34 ± 5.4 | 0.610 |
| NF-κB | 2.13 ± 0.92 | 2.07 ± 1.03 | 0.842 |
| Fibrosis grade (kPa) | 6.52 ± 2.38 | 6.98 ± 2.42 | 0.132 |
| Steatosis grade (db/m) | 315.18 ± 35.69 | 298.35 ± 29.5 | 0.218 |
aData are presented as mean ± SD except for gender, which is reported as number (%)
NAFLD none-alcoholic Fatty Liver Disease, BMI body mass index, TNF tumor necrosis factor, NF-kB Nuclear factor kappa B, hs-CRP high sensitive C reactive protein